Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ximing Tang

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Cancer Research|December 17, 2005
High expression of ErbB family members and their ligands in lung adenocarcinomas that are sensitive to inhibition of epidermal growth factor receptorNobukazu Fujimoto, Marie Wislez, Jie Zhang, et al.
Cell Reports|August 2, 2016
Fatty Acid Oxidation Mediated by Acyl-CoA Synthetase Long Chain 3 Is Required for Mutant KRAS Lung TumorigenesisMahesh S Padanad, Georgia Konstantinidou, Niranjan Venkateswaran, et al.
British Journal of Cancer|May 17, 2024
Epigenetic activation of SOX11 is associated with recurrence and progression of ductal carcinoma in situ to invasive breast cancerWarapen Treekitkarnmongkol, Vandna Shah, Kazuharu Kai, et al.
Leukemia|March 12, 2024
STAT3 protects hematopoietic stem cells by preventing activation of a deleterious autocrine type-I interferon responseBhakti Patel, Yifan Zhou, Rachel L Babcock, et al.
Nature Communications|January 3, 2024
Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA responseMei Zhao, Tianxiao Wang, Frederico O Gleber-Netto, et al.
Nature Structural & Molecular Biology|November 6, 2023
CRISPR-Cas9-based functional interrogation of unconventional translatome reveals human cancer dependency on cryptic non-canonical open reading framesCaishang Zheng, Yanjun Wei, Peng Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2022
Diminished Immune Surveillance during Histologic Progression of Intraductal Papillary Mucinous Neoplasms Offers a Therapeutic Opportunity for Cancer InterceptionSharia Hernandez, Edwin Roger Parra, Naohiro Uraoka, et al.
The Journal of Biological Chemistry|January 28, 2015
Receptor tyrosine kinase EphA5 is a functional molecular target in human lung cancerFernanda I Staquicini, Ming D Qian, Ahmad Salameh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2022
Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLCPedro Rocha, Jiexin Zhang, Raquel Laza-Briviesca, et al.
Journal of the National Cancer Institute|January 17, 2012
Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcomeNathan T Ihle, Lauren A Byers, Edward S Kim, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Cancer Research|December 17, 2005
High expression of ErbB family members and their ligands in lung adenocarcinomas that are sensitive to inhibition of epidermal growth factor receptorNobukazu Fujimoto, Marie Wislez, Jie Zhang, et al.
Cell Reports|August 2, 2016
Fatty Acid Oxidation Mediated by Acyl-CoA Synthetase Long Chain 3 Is Required for Mutant KRAS Lung TumorigenesisMahesh S Padanad, Georgia Konstantinidou, Niranjan Venkateswaran, et al.
British Journal of Cancer|May 17, 2024
Epigenetic activation of SOX11 is associated with recurrence and progression of ductal carcinoma in situ to invasive breast cancerWarapen Treekitkarnmongkol, Vandna Shah, Kazuharu Kai, et al.
Leukemia|March 12, 2024
STAT3 protects hematopoietic stem cells by preventing activation of a deleterious autocrine type-I interferon responseBhakti Patel, Yifan Zhou, Rachel L Babcock, et al.
Nature Communications|January 3, 2024
Mutant p53 gains oncogenic functions through a chromosomal instability-induced cytosolic DNA responseMei Zhao, Tianxiao Wang, Frederico O Gleber-Netto, et al.
Nature Structural & Molecular Biology|November 6, 2023
CRISPR-Cas9-based functional interrogation of unconventional translatome reveals human cancer dependency on cryptic non-canonical open reading framesCaishang Zheng, Yanjun Wei, Peng Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2022
Diminished Immune Surveillance during Histologic Progression of Intraductal Papillary Mucinous Neoplasms Offers a Therapeutic Opportunity for Cancer InterceptionSharia Hernandez, Edwin Roger Parra, Naohiro Uraoka, et al.
The Journal of Biological Chemistry|January 28, 2015
Receptor tyrosine kinase EphA5 is a functional molecular target in human lung cancerFernanda I Staquicini, Ming D Qian, Ahmad Salameh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2022
Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLCPedro Rocha, Jiexin Zhang, Raquel Laza-Briviesca, et al.
Journal of the National Cancer Institute|January 17, 2012
Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcomeNathan T Ihle, Lauren A Byers, Edward S Kim, et al.
Pageof 9